Cargando…

Direct inhibitory effect on viral entry of influenza A and SARS‐CoV‐2 viruses by azithromycin

OBJECTIVES: Using strategy of drug repurposing, antiviral agents against influenza A virus (IAV) and newly emerging SARS‐coronavirus 2 (SARS‐CoV‐2, also as 2019‐nCoV) could be quickly screened out. MATERIALS AND METHODS: A previously reported engineered replication‐competent PR8 strain carrying luci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Xiaohong, Zuo, Xiangyang, Meng, Fang, Han, Chenfeng, Ouyang, Wei, Han, Yu, Gu, Yayun, Zhao, Xin, Xu, Feng, Qin, Frank Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744835/ https://www.ncbi.nlm.nih.gov/pubmed/33211371 http://dx.doi.org/10.1111/cpr.12953

Ejemplares similares

Azithromycin in viral infections
por: Oliver, Madeleine E., et al.
Publicado: (2020)

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
por: Jiang, Shibo, et al.
Publicado: (2010)

Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load
por: Nguyen, Tuan V.
Publicado: (2021)

An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein
por: Yoon, Aerin, et al.
Publicado: (2015)

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
por: Kastenhuber, Edward R, et al.
Publicado: (2022)

Influenza Virus Entry
por: Luo, Ming
Publicado: (2011)

New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides
por: Wu, Wenjiao, et al.
Publicado: (2015)

The Entry Blocker Peptide Produced in Chlamydomonas reinhardtii Inhibits Influenza Viral Replication in vitro
por: Reyes-Barrera, Karen Lizbeth, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Inhibition of Influenza H7 Hemagglutinin-Mediated Entry
por: Antanasijevic, Aleksandar, et al.
Publicado: (2013)

The Inhibitory Effects of Medicinal Herbs on SARS-CoV Entry In Vitro
por: Zhuang, Min, et al.
Publicado: (2007)

Small Molecule Inhibitors of Influenza Virus Entry
por: Chen, Zhaoyu, et al.
Publicado: (2021)

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
por: Pani, Arianna, et al.
Publicado: (2020)

Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
por: Behzadipour, Yasaman, et al.
Publicado: (2022)

Viral cell recognition and entry.
por: Rossmann, M. G.
Publicado: (1994)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

GP96 Interacts with HHV-6 during Viral Entry and Directs It for Cellular Degradation
por: Prusty, Bhupesh K., et al.
Publicado: (2014)

Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis
por: Beigelman, Avraham, et al.
Publicado: (2010)

Ethanolic Extract of Melia Fructus Has Anti-influenza A Virus Activity by Affecting Viral Entry and Viral RNA Polymerase
por: Jin, Young-Hee, et al.
Publicado: (2017)

Inhibitory effect of silibinin on hepatitis B virus entry
por: Umetsu, Teruyuki, et al.
Publicado: (2018)

Pregnancy-induced differential expression of SARS-CoV-2 and influenza a viral entry factors in the lower respiratory tract
por: Giri, Tusar, et al.
Publicado: (2023)

Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry
por: Ao, Zhujun, et al.
Publicado: (2021)

Glucosylceramide synthase maintains influenza virus entry and infection
por: Drews, Kelly, et al.
Publicado: (2020)

Neural stem cell-derived exosomes mediate viral entry
por: Sims, Brian, et al.
Publicado: (2014)

Analysis of the Subunit Stoichiometries in Viral Entry
por: Magnus, Carsten, et al.
Publicado: (2012)

Live cell imaging of viral entry
por: Sun, Eileen, et al.
Publicado: (2013)

Membrane Rafts: Portals for Viral Entry
por: Ripa, Inés, et al.
Publicado: (2021)

Microtubules in Influenza Virus Entry and Egress
por: Simpson, Caitlin, et al.
Publicado: (2020)

Grouper interferon-induced transmembrane protein 3 (IFITM3) inhibits the infectivity of iridovirus and nodavirus by restricting viral entry
por: Zhang, Ya, et al.
Publicado: (2020)

Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019)

Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)
por: Su, Bin, et al.
Publicado: (2009)

Upregulated influenza A viral entry factors and enhanced interferon-alpha response in the nasal epithelium of pregnant rats
por: Giri, Tusar, et al.
Publicado: (2022)

Comparison of azithromycin and erythromycin in the treatment of mycoplasma pneumonia in children
por: Han, Rui, et al.
Publicado: (2020)

Pathogenic Escherichia coli Possess Elevated Growth Rates under Exposure to Sub-Inhibitory Concentrations of Azithromycin
por: Tuan-Anh, Tran, et al.
Publicado: (2020)

Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion
por: Hu, Hua, et al.
Publicado: (2019)

Azithromycin (Zithromax(®))
por: McCarty, James M.
Publicado: (1996)

Azithromycin for Malaria?
por: Rosenthal, Philip J.
Publicado: (2016)

Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant
por: Mhatre, Susmit, et al.
Publicado: (2021)

Filovirus Tropism: Cellular Molecules for Viral Entry
por: Takada, Ayato
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pd0iii7p6efkmodacjs0i288rr